Vor Biopharma Newsroom

Vor Biopharma Price Target Maintained With a $12.00/Share by JMP Securities

Dow JonesDec 10 11:51 ET

Vor Biopharma Analyst Ratings

BenzingaDec 10 11:41 ET

Oppenheimer Maintains Vor Biopharma(VOR.US) With Buy Rating, Maintains Target Price $8

Moomoo NewsDec 9 16:31 ET

Stifel Nicolaus Remains a Buy on Vor Biopharma (VOR)

TipRanksDec 9 07:59 ET

Analysts Offer Insights on Healthcare Companies: Vor Biopharma (VOR), Recursion Pharmaceuticals (RXRX) and AN2 Therapeutics, Inc. (ANTX)

TipRanksNov 25 01:02 ET

Barclays Maintains Vor Biopharma(VOR.US) With Buy Rating, Maintains Target Price $3

Moomoo NewsNov 11 03:35 ET

Vor Biopharma Is Maintained at Outperform by Baird

Dow JonesNov 8 07:41 ET

Vor Biopharma Analyst Ratings

BenzingaNov 8 06:13 ET

Barclays Maintains Vor Biopharma(VOR.US) With Buy Rating, Maintains Target Price $3

Moomoo NewsNov 8 05:37 ET

Barclays Keeps Their Buy Rating on Vor Biopharma (VOR)

TipRanksNov 8 04:53 ET

Analysts Offer Insights on Healthcare Companies: SAB Biotherapeutics (SABS) and Vor Biopharma (VOR)

TipRanksSep 10 10:40 ET

Vor Biopharma Price Target Maintained With a $12.00/Share by JMP Securities

Dow JonesSep 6 11:03 ET

Evercore Initiates Vor Biopharma(VOR.US) With Buy Rating

Moomoo NewsSep 6 08:31 ET

HC Wainwright & Co. Reiterates Buy on Vor Biopharma, Maintains $17.5 Price Target

BenzingaSep 6 06:29 ET

Vor Biopharma Analyst Ratings

BenzingaSep 6 06:24 ET

Barclays Maintains Vor Biopharma(VOR.US) With Buy Rating, Maintains Target Price $3

Moomoo NewsSep 6 05:32 ET

Vor Biopharma (VOR) Receives a Buy From Barclays

TipRanksSep 6 04:57 ET

Promising Clinical Outcomes and Strategic Acquisitions Bolster Buy Rating for Vor Biopharma

TipRanksSep 6 00:39 ET

Vor Biopharma Analyst Ratings

BenzingaAug 14 11:21 ET

Barclays Maintains Vor Biopharma(VOR.US) With Buy Rating, Cuts Target Price to $3

Moomoo NewsAug 14 04:32 ET